DK1023905T3 - Farmaceutisk præparat indeholdende S-nitroso-immunoglobuliner og anvendelse deraf - Google Patents
Farmaceutisk præparat indeholdende S-nitroso-immunoglobuliner og anvendelse derafInfo
- Publication number
- DK1023905T3 DK1023905T3 DK00108908T DK00108908T DK1023905T3 DK 1023905 T3 DK1023905 T3 DK 1023905T3 DK 00108908 T DK00108908 T DK 00108908T DK 00108908 T DK00108908 T DK 00108908T DK 1023905 T3 DK1023905 T3 DK 1023905T3
- Authority
- DK
- Denmark
- Prior art keywords
- nitroso
- immunoglobulins
- pharmaceutical preparation
- preparation containing
- pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6472—Cysteine endopeptidases (3.4.22)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3153—Streptokinase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/795—Porphyrin- or corrin-ring-containing peptides
- C07K14/805—Haemoglobins; Myoglobins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
- C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79166891A | 1991-11-14 | 1991-11-14 | |
US94383592A | 1992-09-14 | 1992-09-14 | |
EP92924388A EP0676964B1 (de) | 1991-11-14 | 1992-11-13 | Die nitrosylierung von enzym-sh gruppen als eine therapeutische massnahme |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1023905T3 true DK1023905T3 (da) | 2005-05-30 |
Family
ID=27121187
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00108908T DK1023905T3 (da) | 1991-11-14 | 1992-11-13 | Farmaceutisk præparat indeholdende S-nitroso-immunoglobuliner og anvendelse deraf |
DK00108907T DK1023900T3 (da) | 1991-11-14 | 1992-11-13 | Farmaceutisk præparat indeholdende S-nitroso-lipoproteiner og anvendelse deraf |
DK92924388T DK0676964T3 (da) | 1991-11-14 | 1992-11-13 | Nitrosylering af enzym-SH-grupper som en terapeutisk modalitet |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00108907T DK1023900T3 (da) | 1991-11-14 | 1992-11-13 | Farmaceutisk præparat indeholdende S-nitroso-lipoproteiner og anvendelse deraf |
DK92924388T DK0676964T3 (da) | 1991-11-14 | 1992-11-13 | Nitrosylering af enzym-SH-grupper som en terapeutisk modalitet |
Country Status (7)
Country | Link |
---|---|
US (5) | US5593876A (de) |
EP (4) | EP0676964B1 (de) |
AU (2) | AU3071592A (de) |
CA (1) | CA2125037C (de) |
DE (3) | DE69233474T2 (de) |
DK (3) | DK1023905T3 (de) |
WO (1) | WO1993009806A1 (de) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6291424B1 (en) * | 1991-11-14 | 2001-09-18 | Brigham And Women's Hospital | Nitrosated and nitrosylated heme proteins |
WO1994022482A1 (en) * | 1993-03-26 | 1994-10-13 | Biorelease Technologies, Inc. | Compositions including heme-containing proteins and methods relating thereto |
AU698748B2 (en) * | 1993-09-17 | 1998-11-05 | Brigham And Women's Hospital | Use of nitric oxide-adducts to prevent thrombosis on artificial and vascular surfaces |
GB9423868D0 (en) * | 1994-11-25 | 1995-01-11 | Wellcome Found | Compounds for use in medicine |
US5703073A (en) | 1995-04-19 | 1997-12-30 | Nitromed, Inc. | Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
US6051588A (en) * | 1995-04-19 | 2000-04-18 | Nitromed Inc | Nitroso esters of β-oxo-amides and aryl propionic acid derivatives of non-steroidal antiinflammatory drugs |
US6043232A (en) * | 1997-07-23 | 2000-03-28 | Nitromed, Inc. | Nitroso esters of beta-oxo-amides and aryl propionic acid derivatives of non-steroidal antiinflammatory drugs |
US5612314A (en) * | 1995-04-21 | 1997-03-18 | Brigham & Women's Hospital | Nitrosylated neuropeptides |
US6627738B2 (en) | 1995-09-15 | 2003-09-30 | Duke University | No-modified hemoglobins and uses therefor |
US6855691B1 (en) | 1995-09-15 | 2005-02-15 | Duke University | Methods for producing and using S-nitrosohemoglobins |
US6911427B1 (en) | 1995-09-15 | 2005-06-28 | Duke University | No-modified hemoglobins and uses therefore |
US6153186A (en) * | 1995-09-15 | 2000-11-28 | Duke University Medical Center | Red blood cells loaded with S-nitrosothiol and uses therefor |
US6916471B2 (en) | 1995-09-15 | 2005-07-12 | Duke University | Red blood cells loaded with S-nitrosothiol and uses therefor |
US6197745B1 (en) | 1995-09-15 | 2001-03-06 | Duke University | Methods for producing nitrosated hemoglobins and therapeutic uses therefor |
US6323211B1 (en) | 1996-02-02 | 2001-11-27 | Nitromed, Inc. | Compositions and methods for treating sexual dysfunctions |
US6469065B1 (en) | 1996-02-02 | 2002-10-22 | Nitromed, Inc. | Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use |
US20020143007A1 (en) * | 1996-02-02 | 2002-10-03 | Garvey David S. | Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use |
US6294517B1 (en) | 1996-02-02 | 2001-09-25 | Nitromed, Inc. | Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use |
US20050065161A1 (en) * | 1996-02-02 | 2005-03-24 | Nitromed, Inc. | Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses |
US5932538A (en) * | 1996-02-02 | 1999-08-03 | Nitromed, Inc. | Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses |
US5994294A (en) * | 1996-02-02 | 1999-11-30 | Nitromed, Inc. | Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses |
US5824669A (en) | 1996-03-22 | 1998-10-20 | Nitromed, Inc. | Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders |
US6057367A (en) | 1996-08-30 | 2000-05-02 | Duke University | Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses |
DE69839553D1 (de) * | 1997-01-08 | 2008-07-10 | Invitrogen Corp | Verfahren zur herstellung von proteinen |
CA2278784A1 (en) * | 1997-02-06 | 1998-08-13 | Jonathan S. Stamler | No-modified hemoglobins and uses therefor |
US6489290B2 (en) * | 1997-03-27 | 2002-12-03 | Trustees Of Boston University | Antiplatelet agent |
WO1998043621A1 (en) * | 1997-03-31 | 1998-10-08 | The Children's Medical Center Corporation | Nitrosylation to inactivate apoptotic enzymes |
WO1998052580A1 (en) * | 1997-05-21 | 1998-11-26 | Duke University | Treating asthma by preventing and/or accommodating for s-nitrosothiol breakdown |
EP1659178B1 (de) * | 1998-02-05 | 2010-03-31 | GlaxoSmithKline Biologicals SA | Verfahren zur Reinigung oder Herstellung der MAGE Protein |
CA2348741C (en) | 1998-10-30 | 2010-04-20 | Nitromed Inc. | Nitrosasted and nitrosylated nonsteroidal antiinflammatory compounds, comositions and methods of use |
ES2147162B1 (es) | 1999-01-27 | 2001-03-16 | Lacer Sa | "s-nitrosotioles como agentes para el tratamiento de disfunciones circulatorias". |
US7045152B2 (en) * | 1999-09-08 | 2006-05-16 | Duke University | Treating pulmonary disorders with gaseous agent causing repletion of GSNO |
US6314956B1 (en) | 1999-09-08 | 2001-11-13 | Duke University | Pulmonary delivery of NO group-containing compound in gas form to treat respiratory, cardiac and blood disorders |
JP2004506221A (ja) * | 2000-08-11 | 2004-02-26 | インヴィトロジェン コーポレーション | 高度に均一な電気泳動用分子マーカー |
US20040014082A1 (en) * | 2000-08-11 | 2004-01-22 | Invitrogen Corporation | Highly homogeneous molecular markers for electrophoresis |
US6417347B1 (en) * | 2000-08-24 | 2002-07-09 | Scimed Life Systems, Inc. | High yield S-nitrosylation process |
US6780849B2 (en) | 2000-12-21 | 2004-08-24 | Scimed Life Systems, Inc. | Lipid-based nitric oxide donors |
ATE437637T1 (de) | 2001-05-02 | 2009-08-15 | Nitromed Inc | Nitrosiertes und nitrosyliertes nebivolol und seine metaboliten, zusammensetzungen und anwendungsverfahren |
EP1427323A4 (de) * | 2001-08-20 | 2004-09-15 | Univ Virginia | Verwendung von s-nitrosothiol-signalisierung zur behandlung von störungen der atmungskontrolle |
US20050261475A1 (en) * | 2004-02-13 | 2005-11-24 | Harvard Medical School | Solid-phase capture-release-tag methods for phosphoproteomic analyses |
GB0415757D0 (en) * | 2004-07-14 | 2004-08-18 | Nat Blood Authority | Methods |
SE0402221D0 (sv) * | 2004-09-14 | 2004-09-14 | Aerocrine Ab | Treatment of insufficient perfusion |
WO2006041855A2 (en) | 2004-10-04 | 2006-04-20 | Nitromed, Inc. | Compositions and methods using apocynin compounds and nitric oxide donors |
EP3556401A1 (de) | 2005-05-27 | 2019-10-23 | The University of North Carolina at Chapel Hill | Stickoxidfreisetzende partikel für stickoxidtherapeutika und biomedizinische anwendungen |
EP1915157A4 (de) | 2005-08-02 | 2010-09-01 | Nicox Sa | Stickoxidverstärkende antimikrobielle verbindungen, zusammensetzungen und verwendungsverfahren |
US8067414B2 (en) | 2006-03-29 | 2011-11-29 | Nicox S.A. | Nitric oxide enhancing prostaglandin compounds, compositions and methods of use |
EP1939179A1 (de) | 2006-12-28 | 2008-07-02 | Lacer, S.A. | Stabile S-Nitrosothiole, Syntheseverfahren und Verwendung |
EP2310065A2 (de) * | 2008-06-26 | 2011-04-20 | Boston Scientific Scimed, Inc. | Aufgeladene materialien enthaltende beschichtungen von medizinprodukten |
EP2334279A4 (de) * | 2008-10-16 | 2013-03-20 | Novan Inc | Stickoxid freisetzende partikel für mundpflegeanwendungen |
KR102210133B1 (ko) | 2009-06-09 | 2021-02-01 | 프로롱 파마슈티컬스, 엘엘씨 | 헤모글로빈 조성물 |
BR112012003792B1 (pt) | 2009-08-21 | 2020-05-19 | Novan Inc | composição tópica, e, uso da composição tópica |
CN102695528B (zh) | 2009-08-21 | 2016-07-13 | 诺万公司 | 创伤敷料、其使用方法及其形成方法 |
EP2488591A1 (de) * | 2009-10-13 | 2012-08-22 | Novan, Inc. | Stickoxidfreisetzende beschichtungen |
US8591876B2 (en) | 2010-12-15 | 2013-11-26 | Novan, Inc. | Methods of decreasing sebum production in the skin |
WO2012118829A2 (en) | 2011-02-28 | 2012-09-07 | Novan, Inc. | Tertiary s-nitrosothiol-modified nitricoxide-releasing xerogels and methods of using the same |
US10213445B2 (en) * | 2014-11-06 | 2019-02-26 | ARIZONA BOARD OF REGENTS on behalf of THE UNIVERSITY OF ARIZONA, A BODY CORPORATE | Compositions and methods of diazeniumdiolate-based prodrugs for treating cancer |
CA3132731A1 (en) | 2019-03-07 | 2020-09-10 | University Of Padova | Compositions and methods of use comprising substances with neural plasticity actions administered at non-psychedelic/psychotomimetic dosages and formulations |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4666884A (en) * | 1984-04-10 | 1987-05-19 | New England Deaconess Hospital | Method of inhibiting binding of von Willebrand factor to human platelets and inducing interaction of platelets with vessel walls |
US5069936A (en) * | 1987-06-25 | 1991-12-03 | Yen Richard C K | Manufacturing protein microspheres |
US5025001A (en) * | 1988-06-15 | 1991-06-18 | Brigham And Women's Hospital | S-nitroso derivatives of ACE inhibitors and the use thereof |
US5002964A (en) * | 1988-06-15 | 1991-03-26 | Brigham & Women's Hospital | S-nitrosocaptopril compounds and the use thereof |
US4900719A (en) * | 1988-08-05 | 1990-02-13 | The Ohio State University | Nitrosothiols as hypotensive agents |
DE69008454T2 (de) * | 1989-08-07 | 1994-08-25 | Takeda Chemical Industries Ltd | Nitrolsothiolderivate, ihre Herstellung und Verwendung. |
US5380758A (en) * | 1991-03-29 | 1995-01-10 | Brigham And Women's Hospital | S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof |
US5385937A (en) * | 1991-04-10 | 1995-01-31 | Brigham & Women's Hospital | Nitrosation of homocysteine as a method for treating homocysteinemia |
US5459076A (en) * | 1992-04-22 | 1995-10-17 | Brigham And Women's Hospital | Method for detecting nitric oxide, nitrosonium equivalents, S-nitrosothiols and S-nitroso-proteins in biological systems |
US5298506A (en) * | 1992-05-08 | 1994-03-29 | Brigham And Women's Hospital | Use of guanylate cyclase inhibitors in the treatment of shock |
US5346599A (en) * | 1993-01-26 | 1994-09-13 | Jonathan Stamler | Capillary zone electrophoretic detection of biological thiols and their S-nitrosated and oxidized derivatives |
US5427797A (en) * | 1993-04-06 | 1995-06-27 | Brigham And Women's Hospital | Systemic effects of nitric oxide inhalation |
-
1992
- 1992-11-13 DK DK00108908T patent/DK1023905T3/da active
- 1992-11-13 DE DE69233474T patent/DE69233474T2/de not_active Expired - Fee Related
- 1992-11-13 CA CA002125037A patent/CA2125037C/en not_active Expired - Fee Related
- 1992-11-13 WO PCT/US1992/009667 patent/WO1993009806A1/en active IP Right Grant
- 1992-11-13 EP EP92924388A patent/EP0676964B1/de not_active Expired - Lifetime
- 1992-11-13 EP EP00108908A patent/EP1023905B1/de not_active Expired - Lifetime
- 1992-11-13 EP EP00108906A patent/EP1025853A3/de not_active Withdrawn
- 1992-11-13 DE DE69233491T patent/DE69233491T2/de not_active Expired - Fee Related
- 1992-11-13 EP EP00108907A patent/EP1023900B1/de not_active Expired - Lifetime
- 1992-11-13 DK DK00108907T patent/DK1023900T3/da active
- 1992-11-13 DE DE69231666T patent/DE69231666T2/de not_active Expired - Fee Related
- 1992-11-13 AU AU30715/92A patent/AU3071592A/en not_active Abandoned
- 1992-11-13 DK DK92924388T patent/DK0676964T3/da active
-
1994
- 1994-08-09 US US08/287,830 patent/US5593876A/en not_active Expired - Fee Related
-
1995
- 1995-05-09 US US08/437,884 patent/US6562344B1/en not_active Expired - Fee Related
-
1997
- 1997-07-03 AU AU28494/97A patent/AU709725B2/en not_active Ceased
- 1997-08-06 US US08/907,217 patent/US5863890A/en not_active Expired - Fee Related
-
2002
- 2002-08-13 US US10/216,865 patent/US7157500B2/en not_active Expired - Fee Related
-
2006
- 2006-05-05 US US11/418,367 patent/US20060198831A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20030007967A1 (en) | 2003-01-09 |
EP0676964A4 (de) | 1995-08-10 |
DE69233474T2 (de) | 2006-03-30 |
DK0676964T3 (da) | 2001-02-05 |
EP0676964B1 (de) | 2001-01-24 |
AU709725B2 (en) | 1999-09-02 |
US7157500B2 (en) | 2007-01-02 |
EP1025853A2 (de) | 2000-08-09 |
AU2849497A (en) | 1997-10-16 |
US5593876A (en) | 1997-01-14 |
EP1023905A2 (de) | 2000-08-02 |
US6562344B1 (en) | 2003-05-13 |
WO1993009806A1 (en) | 1993-05-27 |
EP1023900A3 (de) | 2000-11-08 |
AU3071592A (en) | 1993-06-15 |
DK1023900T3 (da) | 2005-06-06 |
CA2125037C (en) | 2001-02-20 |
DE69233474D1 (de) | 2005-03-03 |
EP1023900A2 (de) | 2000-08-02 |
DE69233491D1 (de) | 2005-04-21 |
EP0676964A1 (de) | 1995-10-18 |
US20060198831A1 (en) | 2006-09-07 |
EP1025853A3 (de) | 2000-11-08 |
EP1023905A3 (de) | 2000-11-08 |
DE69231666D1 (de) | 2001-03-01 |
CA2125037A1 (en) | 1993-05-27 |
DE69231666T2 (de) | 2001-05-10 |
EP1023905B1 (de) | 2005-01-26 |
EP1023900B1 (de) | 2005-03-16 |
DE69233491T2 (de) | 2006-04-06 |
US5863890A (en) | 1999-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1023905T3 (da) | Farmaceutisk præparat indeholdende S-nitroso-immunoglobuliner og anvendelse deraf | |
DK0515312T3 (da) | Farmaceutisk præparat | |
BR1100824A (pt) | Composto e composição farmacêutica | |
EE03108B1 (et) | Farmatseutiline kompositsioon | |
FI981777A0 (fi) | Farmaseuttinen ainekoostumus | |
FI921060A (fi) | Farmaceutiska aerosolformuleringar | |
FI934914A (fi) | Farmaceutiska formuleringar | |
NO921012D0 (no) | Farmasoeytiske preparater og deres anvendelse | |
NO943511D0 (no) | Farmasöytiske preparater og anvendelse derav | |
FI923581A (fi) | Farmaceutisk kombinationsformation | |
BR9200058A (pt) | Composto e composicao farmaceutica | |
MX9200622A (es) | Composicion farmaceutica | |
LV10386A (lv) | Farmaceitiska kompozicija un tas pagatavosanas panemiens | |
DK127691D0 (da) | Mucoadhaesivt baerestof og farmaceutisk doseringsform indeholdende dette baerestof | |
DK287188D0 (da) | Cephalosporinforbindelser og farmaceutisk praeparat deraf | |
NO304890B1 (no) | Farmas°ytiske forbindelser og farmas°ytiske preparater | |
FI934387A0 (fi) | 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner | |
NO178066C (no) | Substituert sulfonamidderivat og farmasöytisk formulering inneholdende det samme | |
NO179907C (no) | Benzokinoksaliner og farmasöytiske preparater inneholdende de samme | |
BR1100486A (pt) | Composto e composição farmacêutica | |
KR920014777U (ko) | 약제 휘산기구 | |
ITMI912766A1 (it) | Composizione farmaceutica contenente n-acetil-cisteina | |
NO941426D0 (no) | Antisporiatiske farmasöytiske preparater og fremgangsmåte for fremstilling av slike | |
DK75791D0 (da) | Novel pharmaceutical preparations | |
NO920564D0 (no) | Farmasoeytiske adenosinholdige preparater |